PACS Group (NYSE:PACS) Price Target Raised to $42.00 at Oppenheimer

PACS Group (NYSE:PACS) had its price target hoisted by equities research analysts at Oppenheimer from $40.00 to $42.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s target price points to a potential upside of 14.29% from the company’s current price.

PACS has been the topic of several other reports. Weiss Ratings reissued a “hold (c-)” rating on shares of PACS Group in a research note on Monday, December 22nd. UBS Group reiterated a “buy” rating and set a $42.00 price objective (down from $50.00) on shares of PACS Group in a report on Thursday, December 18th. Wall Street Zen upgraded PACS Group from a “hold” rating to a “buy” rating in a research note on Sunday, February 15th. Royal Bank Of Canada upped their price target on PACS Group from $47.00 to $52.00 and gave the stock an “outperform” rating in a research note on Friday, February 27th. Finally, Truist Financial set a $40.00 price target on PACS Group in a report on Friday, December 12th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, PACS Group presently has a consensus rating of “Moderate Buy” and an average target price of $44.00.

PACS Group Stock Down 2.8%

Shares of NYSE PACS opened at $36.75 on Wednesday. The company has a 50 day simple moving average of $38.17 and a 200 day simple moving average of $24.80. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.94 and a quick ratio of 0.94. PACS Group has a 1 year low of $7.50 and a 1 year high of $43.08. The firm has a market cap of $5.78 billion, a PE ratio of 29.88, a price-to-earnings-growth ratio of 1.26 and a beta of -0.64.

Institutional Investors Weigh In On PACS Group

A number of hedge funds have recently modified their holdings of PACS. Geode Capital Management LLC boosted its position in PACS Group by 11.5% during the second quarter. Geode Capital Management LLC now owns 952,358 shares of the company’s stock valued at $12,306,000 after buying an additional 98,277 shares during the period. Royce & Associates LP increased its holdings in shares of PACS Group by 76.6% in the third quarter. Royce & Associates LP now owns 1,859,070 shares of the company’s stock worth $25,525,000 after buying an additional 806,446 shares during the period. Corient Private Wealth LLC bought a new stake in shares of PACS Group in the 2nd quarter valued at about $533,000. Los Angeles Capital Management LLC bought a new stake in shares of PACS Group in the 2nd quarter valued at about $1,654,000. Finally, American Alpha Advisors LLC purchased a new stake in PACS Group during the 3rd quarter valued at about $686,000.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.